New York, NY, United States of America

Ming Lei

This inventor holds 1 USPTO granted patent. Top assignee: Columbia University. Active years: 2017.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Ming Lei. Retrieved from https://idiyas.com/inventor/ming-lei-qo6w2n2h

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


Average Co-Inventor Count = 3.0

ph-index = 1

Forward Citations = 15(Granted Patents)


Company Filing History:


Years Active: 2017

Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovations of Ming Lei

Introduction

Ming Lei is an accomplished inventor based in New York, NY. He has made significant contributions to the field of biomedical research, particularly in the culture of prostate organoids. His work has implications for understanding prostate biology and disease.

Latest Patents

Ming Lei holds a patent titled "Method for culture of human and mouse prostate organoids and uses thereof." This invention discloses a methodology for the culture of prostate tissue organoids from both mouse and human prostate, showcasing his innovative approach to tissue engineering.

Career Highlights

Ming Lei is affiliated with Columbia University, where he conducts research and develops new methodologies in the field of organoid culture. His work is pivotal in advancing the understanding of prostate health and disease.

Collaborations

Ming Lei collaborates with notable colleagues, including Michael Y Shen and Chee Wai Chua, enhancing the research output and innovation in their projects.

Conclusion

Ming Lei's contributions to the field of organoid culture represent a significant advancement in biomedical research. His innovative methodologies have the potential to impact prostate health research profoundly.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…